Posts Tagged ‘drug importation’
“These drugs would go through additional shipping, inspection and repackaging. Why would they be cheaper?”
In this editorial, which was published in WBUR’s Cognoscenti on September 2, 2020, writer Sarah Ruth Bates explains why Canadian drug importation is too expensive and elaborate a solution to be effective.
[...]Counterfeit Medicine News for the Week of August 3, 2020
In PSM’s round-up this week: COVID-19 fraud, a new DEA initiative to slow the sale of pill presses, and ongoing counterfeit pill news—including charges filed in the death of L.A. Angels pitcher Tyler Skaggs.
[...]Counterfeit Medicine News for the Week of July 27, 2020
In PSM’s round-up this week: Continuing COVID-19 fraud, counterfeit Botox, and ongoing counterfeit pill news.
[...]Citizens Against Government Waste Warns Drug Importation Executive Orders Will Cost Patients in More Ways Than One
In this July 28, 2020 editorial published in the WasteWatcher blog, Elizabeth Wright argues that the administration’s Executive Order will “encourage more illegal behavior and a greater production of counterfeit drugs from countries like China, Mexico, and India.” Wright is the Director of Health and Public Policy for Citizens Against Government Waste
[...]Counterfeit Medicine News for the Week of July 20, 2020
In PSM’s round-up this week: PSM’s statement about drug importation, The Safeguarding Therapeutics Act, continuing COVID-19 fraud, and ongoing counterfeit pill news.
[...]Statement on Trump Administration Executive Order on Drug Importation
Washington, D.C. (July 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to President Trump’s executive order signed today on the importation of prescription drugs:
[...]Research Study Confirms That Cheap And Safe Drug Importation Is Not Feasible
Research Study Confirms That Cheap And Safe Drug Importation Is Not Feasible Read the abstract for Dr. Acri’s article. In March 2020, the Journal of Pharmaceutical Health Services Research, an official journal of the Royal Pharmaceutical Society, published a study by Dr. Kristina M.L. Acri née Lybecker titled “State Pharmaceutical Importation Programmes: An Analysis of…
[...]Freedom Of Access Act Response From The State of Maine
In June 2019, the governor of Maine signed into law LD 1272, a bill that would allow the state to establish a wholesale Canadian prescription drug importation program. On April 13, 2020, the Partnership for Safe Medicines (PSM) filed a request to receive copies of all submitted responses to Maine’s Request for Comment (RFC) for…
[...]Eight Surprising Things We Learned from Reading the 1,200 Comments Filed with the FDA on Canadian Drug Importation
For 78 days, the Department of Health and Human Services accepted public comment on the proposed rulemaking that would allow states to establish drug importation programs, individuals and organizations submitted 1,210 comments, and PSM read each of them. Here are what we feel are the most important takeaways…
[...]HHS comments come in overwhelmingly against Canadian drug importation proposal
Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.
[...]